FDA Task Force Releases Detailed Report On Proposed Disclosure Measures

Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management

Thursday, May 20, 2010

Comments

Ocular Surgery News

The U.S. Food and Drug Administration's Transparency Task Force has released a report on proposals for increasing the disclosure of information while protecting confidentiality and patient information.

Full Story

Refractive Products and Equipment »
Corneal and Refractive Diagnostics »
Glaucoma Testing Equipment / Glaucoma Products »

The pathology in phacolytic glaucoma is blockage of the trabecular meshwork by:
1. Lens material
2. Erythrocytes
3. Lymphocytes
4. Macrophages
5. Peripheral anterior synechiae
Check The Answer

VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product
3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

FDA Task Force Releases Detailed Report On Proposed Disclosure Measures

Comments

Related Categories

Refractive Products and Equipment »

Corneal and Refractive Diagnostics »

Glaucoma Testing Equipment / Glaucoma Products »

Quick Quiz

The pathology in phacolytic glaucoma is blockage of the trabecular meshwork by:

AdGlare RMR Ad

Cataract Featured Products

VISUPLAN 500 Non-Contact Tonometer

3nethra classic Ophthalmic Imaging Device

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us